Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Journal of Neuroinflammation
|
August 26, 2023
Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosis
Barbara Nuesslein-Hildesheim, Enrico Ferrero, Cindy Schmid, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 18, 2025
A cooperative release of mitochondrial DNA from platelets and neutrophils drives an interferon signature in systemic sclerosis
Stavros Giaglis, André N Tiaden, Simone Häner-Massimi, et al.
Journal of Translational Medicine
|
June 6, 2021
Translational precision medicine: an industry perspective
Dominik Hartl, Valeria de Luca, Anna Kostikova, et al.
Frontiers in Immunology
|
January 11, 2020
Meta-Analysis of <i>in vitro</i>-Differentiated Macrophages Identifies Transcriptomic Signatures That Classify Disease Macrophages <i>in vivo</i>
Hung-Jen Chen, Andrew Y F Li Yim, Guillermo R Griffith, et al.
Journal of Clinical Medicine
|
April 12, 2020
Whole-Genome DNA Methylation Profiling of CD14+ Monocytes Reveals Disease Status and Activity Differences in Crohn's Disease Patients
Andrew Y F Li Yim, Nicolette W Duijvis, Mohammed Ghiboub, et al.
Nature Communications
|
October 6, 2019
The midbody interactome reveals unexpected roles for PP1 phosphatases in cytokinesis
Luisa Capalbo, Zuni I Bassi, Marco Geymonat, et al.
Annals of the Rheumatic Diseases
|
November 6, 2023
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial
Thomas Dörner, Martin Kaul, Antónia Szántó, et al.
Oncogenesis
|
April 7, 2021
CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo
Laura Israël, Anton Glück, Marjorie Berger, et al.
The Journal of Allergy and Clinical Immunology
|
May 26, 2026
Early intervention with secukinumab prevents epigenetic scar development in new-onset psoriasis - STEPIn Mechanistic Sub-study results
Johann E Gudjonsson, Katharina Bier, Swann Gaulis, et al.
Plos One
|
December 28, 2018
A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn's disease patients
Andrew Y F Li Yim, Jessica R de Bruyn, Nicolette W Duijvis, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Journal of Neuroinflammation
|
August 26, 2023
Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosis
Barbara Nuesslein-Hildesheim, Enrico Ferrero, Cindy Schmid, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 18, 2025
A cooperative release of mitochondrial DNA from platelets and neutrophils drives an interferon signature in systemic sclerosis
Stavros Giaglis, André N Tiaden, Simone Häner-Massimi, et al.
Journal of Translational Medicine
|
June 6, 2021
Translational precision medicine: an industry perspective
Dominik Hartl, Valeria de Luca, Anna Kostikova, et al.
Frontiers in Immunology
|
January 11, 2020
Meta-Analysis of <i>in vitro</i>-Differentiated Macrophages Identifies Transcriptomic Signatures That Classify Disease Macrophages <i>in vivo</i>
Hung-Jen Chen, Andrew Y F Li Yim, Guillermo R Griffith, et al.
Journal of Clinical Medicine
|
April 12, 2020
Whole-Genome DNA Methylation Profiling of CD14+ Monocytes Reveals Disease Status and Activity Differences in Crohn's Disease Patients
Andrew Y F Li Yim, Nicolette W Duijvis, Mohammed Ghiboub, et al.
Nature Communications
|
October 6, 2019
The midbody interactome reveals unexpected roles for PP1 phosphatases in cytokinesis
Luisa Capalbo, Zuni I Bassi, Marco Geymonat, et al.
Annals of the Rheumatic Diseases
|
November 6, 2023
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial
Thomas Dörner, Martin Kaul, Antónia Szántó, et al.
Oncogenesis
|
April 7, 2021
CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo
Laura Israël, Anton Glück, Marjorie Berger, et al.
The Journal of Allergy and Clinical Immunology
|
May 26, 2026
Early intervention with secukinumab prevents epigenetic scar development in new-onset psoriasis - STEPIn Mechanistic Sub-study results
Johann E Gudjonsson, Katharina Bier, Swann Gaulis, et al.
Plos One
|
December 28, 2018
A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn's disease patients
Andrew Y F Li Yim, Jessica R de Bruyn, Nicolette W Duijvis, et al.
Page
of 3